Evaluation of the Effect of Pelvic Floor Physical Therapy on Patients With 3rd and 4th Degree Obstetrical Lacerations

Sponsor
Boston Urogynecology Associates (Other)
Overall Status
Unknown status
CT.gov ID
NCT02304016
Collaborator
(none)
40
2
2
75
20
0.3

Study Details

Study Description

Brief Summary

The purpose of this study is to determine if patients with third and fourth degree obstetric lacerations benefit from a short course of pelvic floor physical therapy in the immediate postpartum period.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Pelvic floor physical therapy
N/A

Detailed Description

The proposed study is a prospective, randomized pilot trial. We aim to answer the question:

do patients with third and fourth degree obstetric lacerations benefit from a short course pelvic floor physical therapy in the immediate postpartum period?

Forty patients experiencing third or fourth degree obstetric laceration at either BIDMC or Mount Auburn Hospital will be identified and randomized in a 1:1 ratio. Half of the patients will receive a 10-12 week course of pelvic floor physical therapy at Marathon PT to begin one to two weeks postpartum. Those assigned to the control will not receive pelvic floor physical therapy which is the current standard of care. They will also agree not to seek pelvic floor physical therapy during until at least 14 weeks postpartum without discussing with study investigators. At 14 weeks postpartum they will be offered pelvic floor physical therapy. At 1-2 weeks postpartum, 6-8 weeks postpartum, and 12-14 weeks postpartum, all study subjects will complete the Pelvic Floor Impact Questionnaire - 7 (PFIQ-7), the Pelvic Floor Distress Inventory - 20 (PFDI-20), the Female Sexual Function Index (FSFI), the Patient Global Impression of Severity (PGI-S) Scale and the Patient Global Impression of Improvement (PGI-I) Scale all of which are validated surveys. Surveys will be completed online via REDCap using computers at Marathon PT for treatment group subjects and at home or in a location of their choosing for control subjects. Control patients will be given the option of beginning pelvic floor PT after 14 weeks postpartum. Should they decide to pursue pelvic floor PT at that time, they will have the option to continue to fill out periodic surveys via REDCap, but will not be required to do so.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Evaluation of the Effect of Pelvic Floor Physical Therapy on Patients With 3rd and 4th Degree Obstetrical Lacerations
Study Start Date :
Dec 1, 2014
Anticipated Primary Completion Date :
Mar 1, 2020
Anticipated Study Completion Date :
Mar 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Pelvic floor physical therapy

Behavioral: Pelvic floor physical therapy
Patients in this arm will be receiving pelvic floor physical therapy

No Intervention: Observatoin

Outcome Measures

Primary Outcome Measures

  1. Improvement in pelvic floor function (change in PFDI-20) [12-24 weeks]

    The primary outcome will be the change in PFDI-20 from baseline to the final assessment at approximately 12-24 weeks postpartum

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Vaginal delivery at either BIDMC or Mt. Auburn Hospital complicated by either third or fourth degree perineal laceration

  • Age 18 or older

Exclusion Criteria:
  • History of previous vaginal delivery after 24 weeks gestation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Beth Israel Deaconess Medical Center Boston Massachusetts United States 02215
2 Mount Auburn Hospital Cambridge Massachusetts United States 02138

Sponsors and Collaborators

  • Boston Urogynecology Associates

Investigators

  • Principal Investigator: Eman Elkadry, MD, Harvard Medical School (HMS and HSDM)

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Eman Elkadry, M.D., Clinical Instructor, Boston Urogynecology Associates
ClinicalTrials.gov Identifier:
NCT02304016
Other Study ID Numbers:
  • 2014P000141
First Posted:
Dec 1, 2014
Last Update Posted:
Feb 25, 2019
Last Verified:
Feb 1, 2019
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 25, 2019